New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment
Tirzepatide, a medication authorized to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardless of the patient's body mass index (BMI before treatment), from the range of overweight to class III obesity.
Mar 13, 2024
0
0